Medication info

Hyubis D Tablet

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Tripotassium Bismuth Dicitrate›200mg / 1 tabletRanitidine Hydrochloride›168mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Hyubist Pharmaceutical Co., Ltd.
Appearance
Light green oblong film-coated tablets
Packaging
For domestic use - 10 tablets/bottle, For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201904415 · Approved 2019.06.27

This product's status changed to Approval withdrawn on 2024.03.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers and gastritis); prevention of Mendelson syndrome before anesthesia
Who takes it
Adults
Adult dose
○ Adults Usually, 1 tablet is administered orally twice daily, in the morning and before bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily before bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and before bedtime. The same dosage applies to concomitant treatment of ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily before bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily or 2 tablets once daily before bedtime for 8 weeks. However, the dose may be increased to 2 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Hyubist Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers and gastritis); prevention of Mendelson syndrome before anesthesia

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAIDs
View approved original text

This medication is used to treat ulcers of the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing Mendelson's syndrome before anesthesia, and in treating postoperative ulcers and NSAID-induced gastric and duodenal ulcers. It helps improve various gastric disorders.

How to take

Adult dose

○ Adults Usually, 1 tablet is administered orally twice daily, in the morning and before bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily before bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and before bedtime. The same dosage applies to concomitant treatment of ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily before bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily or 2 tablets once daily before bedtime for 8 weeks. However, the dose may be increased to 2 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with impaired kidney function. Patients who have experienced allergic reactions to this medication or its components should also not receive it. Patients with a history of acute porphyria should be cautious as this medication may worsen symptoms. It is not recommended for patients who have undergone gastrointestinal surgery, pregnant women or women who may become pregnant, as well as premature infants or newborns. Patients on a diet restricting potassium intake should also avoid this medication. Caution is required when administering to patients with impaired liver function, a history of drug allergies, the elderly, and those with a history of kidney dysfunction. When taken in conjunction with NSAIDs, particularly elderly patients or those with a history of peptic ulcer should have their conditions monitored regularly. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or those above middle age experiencing new or changing symptoms of dyspepsia should be evaluated for malignancy before treatment. Patients with Helicobacter pylori-positive gastric and duodenal ulcers require eradication therapy. Patients in severe care units, patients with hypophosphatemia, and those with dysphagia should be careful as side effects may occur after administration of this medication. When using this drug, serious allergic reactions such as shock or hypersensitivity may rarely occur; if unusual symptoms appear, treatment should be stopped immediately, and appropriate medical care should be sought. Blood-related side effects may include rare occurrences of leukopenia, thrombocytopenia, and bone marrow suppression; symptoms should be reported to a healthcare professional immediately. Transitory hepatic abnormalities may occur; if hepatitis symptoms arise, use of the medication should be stopped immediately. Gastrointestinal symptoms such as arrhythmia, nausea, diarrhea, and abdominal pain may appear. Central nervous system side effects such as dizziness, drowsiness, confusion, and seizures may rarely occur, and careful observation is required. Muscle pain or joint pain may indicate side effects, so consultation with healthcare professionals is advised. Skin-related side effects such as rashes or hair loss have also been reported rarely. It is advisable not to use this medication for an extended period, and if treatment effects are lacking, it should be switched to another medication. The elderly, patients with chronic lung disease, diabetes, and those with compromised immunity may face an increased risk of pneumonia and should be cautious. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so especially for those taking anticoagulants or certain antibiotics and anticonvulsants, consultation with healthcare professionals is necessary. It is safest not to use this medication during pregnancy or breastfeeding. Safety in children has not been established, and use is not recommended. In cases of overdose, procedures such as vomiting or gastric lavage may be needed, and in some cases, blood dialysis may be used to remove the drug. This medication reduces gastric acid secretion, which can promote bacterial growth in the gastrointestinal tract, so ocular examinations may be required for prolonged use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • leukopenia
Show 64 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulosis
  • pancytopenia
  • bone marrow hypoplasia
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness of the head
  • disease perception
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • tensed muscle spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's efficacy for a long time.

Appearance and packaging

Appearance

Light green oblong film-coated tablets

Package unit

For domestic use - 10 tablets/bottle, For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.